HIGHLIGHTS
- who: Toru Sugiyama from the Tokyo, ‑8324, Japan Department of Obstetrics and Gynecology, Keio University have published the research: Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice, in the Journal: (JOURNAL)
- what: The aim of this study was to ascertain further details regarding fistula occurrence and treatments before bevacizumab administration to review the clinical course of patients with fistula development. This study was conducted in compliance with the Declaration of Helsinki and the Ethical Guidelines for Medical Research in Humans, and approved by the IRB . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.